The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
 
Emerson Yu-sheng Chen
Other Relationship - Horizon CME; Horizon CME; Horizon CME; Horizon CME; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Garth William Tormoen
No Relationships to Disclose
 
Adel Kardosh
Consulting or Advisory Role - Exelixis; Exelixis; Exelixis; Exelixis
 
Nima Nabavizadeh
No Relationships to Disclose
 
Bryan Foster
No Relationships to Disclose
 
Skye C. Mayo
No Relationships to Disclose
 
Kevin G. Billingsley
No Relationships to Disclose
 
Erin W. Gilbert
Stock and Other Ownership Interests - Merck; Merck; Merck; Merck
 
Christian Lanciault
No Relationships to Disclose
 
Aaron Grossberg
No Relationships to Disclose
 
Kenneth Gregory Bensch
No Relationships to Disclose
 
Erin Maynard
No Relationships to Disclose
 
Eric C. Anderson
No Relationships to Disclose
 
Brett C. Sheppard
No Relationships to Disclose
 
Charles R. Thomas
Employment - AMA; AMA; AMA; AMA
Consulting or Advisory Role - AMA; AMA; AMA; AMA
Travel, Accommodations, Expenses - Lilly; Lilly; Lilly; Lilly
 
Charles D. Lopez
Consulting or Advisory Role - Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Scientific; Boston Scientific; Boston Scientific; Boston Scientific; Celgene; Celgene; Celgene; Celgene; Exelixis; Exelixis; Exelixis; Exelixis; Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - RenovoRx; RenovoRx; RenovoRx; RenovoRx
 
Gina M. Vaccaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Alexion Pharmaceuticals; Alexion Pharmaceuticals; Alexion Pharmaceuticals; Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Exelixis; Exelixis; Exelixis; Exelixis; Genentech; Genentech; Genentech; Genentech; Incyte; Incyte; Incyte; Incyte; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Boston Scientific; Boston Scientific; Boston Scientific; Boston Scientific; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Incyte; Incyte; Incyte; Incyte; Lilly; Lilly; Lilly; Lilly; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Newlink Genetics; Newlink Genetics; Newlink Genetics; Newlink Genetics; Polaris; Polaris; Polaris; Polaris